Follow
On March 25, 2021, Japan Ministry of Health, Labour and Welfare (MHLW) issued and implemented four documents, which revised the ingredient standards and adjusted the corresponding pre-market application requirements of quasi-drug products.
To facilitate enterprises' applications for the manufacture and sale of quasi-drugs, MHLW also released a FAQs collection, which includes 29 questions relating to the marketing/manufacturing approval of quasi-drugs/cosmetics, formula and test methods, etc.
Unlock the full page to explore detailed requirements, regulatory updates, company obligations, etc.
Original regulatory document
English translation
Regulation details
Other 1000+ key regulations and when available, their English translation
Laws & Regulations
News & Alerts
Webinars & Reports
Other useful functions
Request a Demo
